Generation R Study Group, Erasmus University Medical Center, Rotterdam, CA 3000, The Netherlands.
Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus University Medical Center, Rotterdam, CA 3000, The Netherlands.
Eur J Endocrinol. 2023 Aug 2;189(2):164-174. doi: 10.1093/ejendo/lvad086.
Genome-wide association studies in adults have identified 42 loci associated with thyroid stimulating hormone (TSH) and 21 loci associated with free thyroxine (FT4) concentrations. While biologically plausible, age-dependent effects have not been assessed. We aimed to study the association of previously identified genetic determinants of TSH and FT4 with TSH and FT4 concentrations in newborns and (pre)school children.
We selected participants from three population-based prospective cohorts with data on genetic variants and thyroid function: Generation R (N = 2169 children, mean age 6 years; N = 2388 neonates, the Netherlands), the Avon Longitudinal Study of Parents and Children (ALSPAC; N = 3382, age 7.5 years, United Kingdom), and the Brisbane Longitudinal Twin Study (BLTS; N = 1680, age 12.1 years, Australia). The association of single nucleotide polymorphisms (SNPs) with TSH and FT4 concentrations was studied with multivariable linear regression models. Weighted polygenic risk scores (PRSs) were defined to combine SNP effects.
In childhood, 30/60 SNPs were associated with TSH and 11/31 SNPs with FT4 after multiple testing correction. The effect sizes for AADAT, GLIS3, TM4SF4, and VEGFA were notably larger than in adults. The TSH PRS explained 5.3%-8.4% of the variability in TSH concentrations; the FT4 PRS explained 1.5%-4.2% of the variability in FT4 concentrations. Five TSH SNPs and no FT4 SNPs were associated with thyroid function in neonates.
The effects of many known thyroid function SNPs are already apparent in childhood and some might be notably larger in children as compared to adults. These findings provide new knowledge about genetic regulation of thyroid function in early life.
成人全基因组关联研究已确定了 42 个与促甲状腺激素(TSH)相关的位点和 21 个与游离甲状腺素(FT4)浓度相关的位点。虽然这些关联具有生物学意义,但尚未评估其与年龄的相关性。我们旨在研究先前鉴定的 TSH 和 FT4 遗传决定因素与新生儿和(学前)儿童 TSH 和 FT4 浓度之间的关联。
我们从三个具有遗传变异和甲状腺功能数据的基于人群的前瞻性队列中选择了参与者:荷兰的 Generation R 队列(有 2169 名儿童,平均年龄为 6 岁;有 2388 名新生儿)、英国的 Avon Longitudinal Study of Parents and Children(ALSPAC)队列(有 3382 名儿童,年龄为 7.5 岁)和澳大利亚的 Brisbane Longitudinal Twin Study(BLTS)队列(有 1680 名儿童,年龄为 12.1 岁)。使用多变量线性回归模型研究了单核苷酸多态性(SNP)与 TSH 和 FT4 浓度之间的关联。定义了加权多基因风险评分(PRS)来组合 SNP 效应。
在儿童期,经过多重检验校正后,有 30/60 个 SNP 与 TSH 相关,有 11/31 个 SNP 与 FT4 相关。AADAT、GLIS3、TM4SF4 和 VEGFA 的效应大小明显大于成人。TSH PRS 解释了 TSH 浓度变异性的 5.3%-8.4%;FT4 PRS 解释了 FT4 浓度变异性的 1.5%-4.2%。有 5 个 TSH SNP 和没有 FT4 SNP 与新生儿的甲状腺功能有关。
许多已知的甲状腺功能 SNP 的影响在儿童期已经很明显,而且在儿童期与成人相比,这些 SNP 的影响可能明显更大。这些发现为早期生命中甲状腺功能的遗传调控提供了新的知识。